|Student Contribution Band:||Band 2|
|Administered by:||College of Medicine & Dentistry|
This subject will explore advanced pharmacy practice including new and expanded roles for pharmacists in various care settings as well as various aspects of clinical pharmaceutics. Students will be introduced to the theory and practice standards underpinning pharmacy prescribing, home medicines reviews (HMR) and pharmacists in general practice (GP) clinics. At this stage, it is expected that students will have acquired sufficient knowledge to fully appreciate the significance of bringing a new drug candidate to market, allowing for the process of drug development to be explored in depth. Students will finalise their group project activities. Students will present their project findings in both written and oral formats and be required to respond to examiner and audience questions regarding their project design, findings conclusions and recommendations. Students will also be required to critically reflect on their performance (as individuals and a team) in undertaking the project and discuss their learning from engagement in the project as a whole.
Compulsory residential attendance is required for successful completion of this subject.
|As this is a core level 4 subject in the BPharm(Hons)/MPharm pathway, students will be expected to have completed all core level 1, 2 and 3 subjects|
|Prerequisites:||PC3314 AND PC3312 AND PC4412|
|Townsville, Mixed attendance, Study Period 2|
|Census Date 26-Aug-2021|
|Face to face teaching (4 week on-campus teaching block; Residential)|
The student workload for this 6 credit point subject is approximately 260 hours.
Note: Minor variations might occur due to the continuous Subject quality improvement process, and in case of minor variation(s) in assessment details, the Subject Outline represents the latest official information.